Institutional investors purchased a net $85.7 thousand shares of MBOT during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 0.43% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
METLIFE SECURITIES, INC. Bought 1.00 shares of Microbot Medical Inc
CREATIVE PLANNING, INC. Sold 99.00 shares of Microbot Medical Inc